JPH06145047A - Hydrous skin patch for external use having improved utility - Google Patents

Hydrous skin patch for external use having improved utility

Info

Publication number
JPH06145047A
JPH06145047A JP4322428A JP32242892A JPH06145047A JP H06145047 A JPH06145047 A JP H06145047A JP 4322428 A JP4322428 A JP 4322428A JP 32242892 A JP32242892 A JP 32242892A JP H06145047 A JPH06145047 A JP H06145047A
Authority
JP
Japan
Prior art keywords
skin
sensitive adhesive
adhesive layer
pressure
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4322428A
Other languages
Japanese (ja)
Other versions
JP2887548B2 (en
Inventor
Masato Oouchi
将斗 大内
Yuji Matsumura
裕司 松村
Atsushi Sato
佐藤  淳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAEDA YAKUHIN KOGYO KK
Original Assignee
MAEDA YAKUHIN KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAEDA YAKUHIN KOGYO KK filed Critical MAEDA YAKUHIN KOGYO KK
Priority to JP4322428A priority Critical patent/JP2887548B2/en
Publication of JPH06145047A publication Critical patent/JPH06145047A/en
Application granted granted Critical
Publication of JP2887548B2 publication Critical patent/JP2887548B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a skin patch for external use having flexibility, and no feeling of physical disorder in application, not dropping from skin, not requiring other fixation assisting means, having neither rash symptoms nor keratin layer damage during peeling. CONSTITUTION:A hydrous skin patch for external use comprises 15-60% water, 2-20% water-insoluble tackifier resin such as ester gum, 0.4-10% dissolving agent for the tackifier resin, such as liquid paraffin and 0.1-30% oil absorbing inorganic powder such as kaolin and is equipped with a tacky agent layer having 100-1,000mum thickness.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は粘着剤層中に、水、粘着
付与性樹脂及びその溶解剤、吸油性無機性粉末を必須の
構成成分として含有し、医薬等に用いることのできる皮
膚に直接貼付して用いる含水性皮膚外用貼付剤に関す
る。
BACKGROUND OF THE INVENTION The present invention contains water, a tackifying resin and its solubilizer, and an oil-absorbing inorganic powder as essential constituents in a pressure-sensitive adhesive layer, and is applied to skin which can be used for medicines and the like. The present invention relates to a hydrous external skin patch for direct use.

【0002】[0002]

【従来の技術】古来、種々の外用的手段によって全身
的、局所的な疾病を治療しようとする試みがなされてき
た。液剤、軟膏剤等の塗布による手段は薬剤が被服によ
ってこすり取られたりするため比較的頻回に薬剤を塗布
することが必要であり、しかも被服等が薬剤で汚染さ
れ、また、疾患部位を保護できないといった欠点を有
し、それらを防止するために包帯等で被覆するという補
助的手段を要する。
2. Description of the Related Art Since ancient times, attempts have been made to treat systemic and local diseases by various external means. Means of applying liquids, ointments, etc. need to be applied relatively often because the drug is scraped off by clothes, and moreover, clothes are contaminated with drugs and the diseased part is protected. It has the drawback of not being able to do so, and requires an auxiliary means of covering with a bandage or the like to prevent them.

【0003】この様な問題点を解決するために皮膚外用
貼付剤の形態が一般的に知られているが、その一形態で
ある、ゴム質粘着剤、アクリル樹脂粘着剤等を用い、実
質的に水を含有しない、いわゆる硬膏剤、テープ剤にお
いてはそれ自身強い粘着力を有し、しかもそれ自身が比
較的薄い(担持体と粘着剤層を合せても1mm以下)た
め疾患部位に貼付しても容易にはがれず、疾患部位を保
護できるという、塗布剤にみられない長所を有している
が、長時間にわたって皮膚面を閉塞状態におくことによ
るかぶれ症状の発現、また、強い粘着力のために剥離時
に強い物理的刺激を生じ体毛をむしり取ったり、皮膚角
質層を損傷することによる皮膚炎の発生がかなり高頻度
にみられ、その性質のために有毛体部への貼付が躊躇さ
れるという欠点を有する。
In order to solve such a problem, the form of the external skin patch is generally known. One of the forms is a rubber adhesive, an acrylic resin adhesive, etc. So-called plasters and tapes, which do not contain water, have a strong adhesive force by themselves and are relatively thin (1 mm or less even if the carrier and the adhesive layer are combined), so it is applied to the diseased site. Even though it does not come off easily, it has the advantage that it can protect the diseased part, which is not found in the application agent, but it causes rash symptoms due to the obstruction of the skin surface for a long time, and strong adhesion. Due to the strong force, strong physical irritation is caused during peeling, the hair is peeled off, and dermatitis due to damage to the stratum corneum of the skin is frequently seen.Because of its nature, application to the hair body part is difficult. The drawback of being hesitated To.

【0004】もう一つの形態である比較的高含水量のい
わゆる成型パップ剤は、硬膏剤、テープ剤の有する前述
の様な物理的皮膚刺激といった問題はなく、水を含有す
ることから皮膚面の閉塞状態は緩和され、かぶれ症状の
発現の頻度もかなり軽減されるが、それ自身の粘着力は
弱く、従って粘着剤層の厚さを厚くして粘着力を出さざ
るを得ず、それ自身が比較的厚い(担持体と粘着剤層を
合せると1.5mm以上)ため柔軟性に欠け、貼付時に
違和感があり脱落し易く、確実な固定のためには包帯
や、固定用粘着テープといった補助的手段を要するのが
通例である。
The so-called molded poultice having a relatively high water content, which is another form, does not have the problem of physical skin irritation that plasters and tapes have, as described above. Although the occlusion state is relieved and the frequency of occurrence of rash symptoms is considerably reduced, the adhesive strength of itself is weak, and therefore the adhesive layer must be thickened to provide adhesive strength, and Since it is relatively thick (1.5 mm or more when the carrier and adhesive layer are combined), it lacks flexibility, and it feels uncomfortable when attached and easily falls off. For reliable fixing, it is an auxiliary material such as a bandage or a fixing adhesive tape. It usually requires some means.

【0005】[0005]

【発明が解決しようとする課題】従来公知の含水性成型
パップ剤に於いては皮膚刺激といった問題はないもの
の、粘着剤層の厚さを薄くした時には粘着力が低下し、
実質上貼着剤としての用をなさなくなるのが通例であ
り、薄くて、しかも十分な粘着力を有する含水性成型パ
ップ剤を提供することは不可能であった。一方、公知の
硬膏剤、テープ剤にあっては粘着剤層の厚さを薄くして
も十分な粘着力を付与することは可能であるが皮膚刺激
といった問題は避け難かった。従って従来技術によって
は皮膚刺激のない、しかも薄くて十分な粘着力を有し貼
付時に脱落することのない、使用性にも優れた皮膚外用
貼付剤を提供することは不可能であった。
Although there are no problems such as skin irritation in the conventionally known hydrous molded poultices, when the thickness of the pressure-sensitive adhesive layer is reduced, the tackiness decreases.
It is customary that it will not be practically used as a patch, and it has been impossible to provide a water-containing molded poultice that is thin and has sufficient adhesive strength. On the other hand, in the case of known plasters and tapes, it is possible to give a sufficient adhesive force even if the thickness of the adhesive layer is thin, but it is difficult to avoid the problem of skin irritation. Therefore, it has been impossible to provide a skin external patch that is not irritating to the skin, is thin and has sufficient adhesive force, and does not fall off during application, and is excellent in usability by the conventional techniques.

【0006】本発明は上記従来公知の皮膚外用貼付剤の
有する欠点を解決しようとするものであり、その目的と
するところは、硬膏剤、テープ剤の有する貼付時の違和
感のなさ、脱落し難さといった優れた性質を保持しなが
ら、パップ剤の有する皮膚安全性をも保持する、使用性
に優れた新たな含水性皮膚外用貼付剤を提供しようとす
るものである。
[0006] The present invention is intended to solve the drawbacks of the above-mentioned conventionally known external patch for skin, and its object is to make plasters and tapes have no discomfort at the time of application and to be hard to drop off. It is intended to provide a new hydrous external skin patch which is excellent in usability and which also retains the skin safety of a poultice, while maintaining excellent properties such as roughness.

【0007】[0007]

【課題を解決するための手段】本発明者らは鋭意研究の
結果その粘着剤組成物中に水、粘着付与性樹脂及びその
溶解剤、吸油性無機性粉末を必須の構成成分として配合
することによって、従来公知の皮膚外用貼付剤の有して
いた欠点を一挙に解消し、極めて優れた使用性を有する
新たな含水性皮膚外用貼付剤が得られることを見い出し
て本発明を完成するに至った。
Means for Solving the Problems As a result of earnest research, the present inventors have added water, a tackifying resin and its solubilizer, and an oil-absorbing inorganic powder to the adhesive composition as essential constituents. According to the present invention, the disadvantages of the conventionally known external skin patches were solved all at once, and it was found that a new hydrous external skin patch having extremely excellent usability was obtained, and the present invention was completed. It was

【0008】すなわち本発明は、担持体上に水、粘着付
与性樹脂及びその溶解剤、吸油性無機性粉末を必須の構
成成分として含有する、均一に混合して製した粘着剤層
を設けて成り、その厚さが100〜1000μmである
含水性皮膚外用貼付剤を提供しようとするものである。
That is, the present invention provides a pressure-sensitive adhesive layer containing water, a tackifying resin and its solubilizer, and an oil-absorbing inorganic powder as essential components on a support, and prepared by mixing them uniformly. The present invention is intended to provide a hydrous external skin patch having a thickness of 100 to 1000 μm.

【0009】従来の硬膏剤、テープ剤等では水を含有さ
せることができず、それによって皮膚刺激といった問題
は避け難かったが、本発明の粘着剤組成物に於いては水
を含むことが特徴の一つであり、その配合量は本粘着剤
組成物の15〜60重量%、更に好ましくは20〜50
重量%である。
[0009] Conventional plasters, tapes and the like cannot contain water, so that the problem of skin irritation was difficult to avoid, but the adhesive composition of the present invention is characterized by containing water. The content of the adhesive composition is 15 to 60% by weight, more preferably 20 to 50% by weight.
% By weight.

【0010】また、本発明に使用される粘着付与性樹脂
としては、ロジン系樹脂、テルペン系樹脂、石油系樹脂
等ほとんど水不溶性の樹脂類があげられるが、その配合
量は本粘着剤組成物の2〜20重量%、更に好ましくは
5〜20重量%である。2重量%未満では実質的に配合
する意味がないし、20重量%以上では剥離ライナーフ
ィルムからの剥離性が低下するなど、製造に困難をきた
す。
Examples of the tackifying resin used in the present invention include rosin-based resins, terpene-based resins, petroleum-based resins, and other almost water-insoluble resins. 2 to 20% by weight, more preferably 5 to 20% by weight. If it is less than 2% by weight, there is no point in blending it substantially, and if it is 20% by weight or more, the peelability from the release liner film is lowered, which causes difficulty in production.

【0011】粘着付与性樹脂の溶解剤としては牛脂、豚
脂等の動物油、オリーブ油、ゴマ油、大豆油等の植物
油、ワセリン、流動パラフィン等の鉱物油、中鎖脂肪酸
トリグリセライド等、粘着付与性樹脂を溶解するもので
あればいずれでもよいが、常温で液状を呈するものが本
発明品の粘着性を減ずることが少なく良好に使用でき、
その配合量は所定量の粘着付与性樹脂を溶解できる量で
あればどれだけでもよいが、過量は粘着剤層の保型性を
弱めたりするため、製造時の取り扱いの容易さ等を考慮
して必要な最小量を用いることが好ましく、その配合量
は粘着付与性樹脂の所定量に対して1/5〜1/2であ
り、本粘着剤組成物中においては0.4〜10重量%で
ある。
As the tackifier resin solubilizer, tackifier resins such as animal oils such as beef tallow and lard, vegetable oils such as olive oil, sesame oil and soybean oil, mineral oils such as petrolatum and liquid paraffin, and medium chain fatty acid triglyceride can be used. Any one may be used as long as it dissolves, but those that are liquid at room temperature can be used favorably without decreasing the tackiness of the product of the present invention,
The blending amount may be any amount as long as it can dissolve a predetermined amount of tackifying resin, but an excessive amount may weaken the shape retention of the pressure-sensitive adhesive layer. It is preferable to use the necessary minimum amount, and the blending amount is 1/5 to 1/2 with respect to the predetermined amount of the tackifying resin, and 0.4 to 10% by weight in the present pressure-sensitive adhesive composition. Is.

【0012】吸油性無機性粉末としては、カオリン、タ
ルク、二酸化ケイ素、メタケイ酸アルミン酸マグネシウ
ム等があげられ、これらの成分は20〜400v/w%
の吸油能力を有するものであるが、これらの一種または
二種以上を組み合わせて使用でき、その配合量は本粘着
剤組成物の0.1〜30重量%、更に好ましくは1〜1
5重量%である。0.1重量%未満では実質的に配合す
る意味がないし、30重量%以上では得られる貼付剤が
硬くなって柔軟性を失い好ましくない。本発明に於いて
本成分は、粘着付与性樹脂の溶解剤として配合された油
成分を吸着し、含水性基剤中に粘着付与性樹脂を安定的
に保持する機能を示すものと考えられ、後述する試験例
5の結果によれば本成分を含有しない比較例では保存安
定性が不良であり、本成分が本発明を構成する重要な成
分であることが判る。
Examples of the oil-absorbing inorganic powder include kaolin, talc, silicon dioxide, magnesium aluminometasilicate and the like, and these components are 20 to 400 v / w%.
It has an oil absorption capacity of 1), but these can be used alone or in combination of 2 or more, and the compounding amount thereof is 0.1 to 30% by weight of the pressure-sensitive adhesive composition, more preferably 1 to 1%.
It is 5% by weight. If it is less than 0.1% by weight, there is no point in blending it substantially, and if it is 30% by weight or more, the obtained patch becomes hard and loses flexibility, which is not preferable. In the present invention, this component is considered to exhibit a function of adsorbing an oil component blended as a solubilizer of a tackifying resin and stably holding the tackifying resin in a water-containing base, According to the results of Test Example 5 described later, the storage stability is poor in Comparative Examples not containing this component, and it is understood that this component is an important component constituting the present invention.

【0013】本発明の含水性皮膚外用貼付剤に於いて粘
着剤層の厚さはとりわけ重要である。一般に粘着剤層の
厚さを厚くすると粘着力は増大するが、逆に柔軟性は低
下し、貼付時の違和感が増大し、脱落し易くなる。従来
公知の含水性成型パップ剤に於いてはそれ自身の粘着力
は比較的弱く、ある程度の粘着力を期待するにはある程
度の厚みが必要であり、従ってどうしても貼付時の脱落
といった問題は避け難かった。粘着付与性樹脂を必須の
構成成分として成る本発明の含水性皮膚外用貼付剤によ
れば、粘着剤層を薄くしても十分な粘着力を有するの
で、使用性の改善といった本発明の趣旨からすれば、可
能な限り薄くすることが好ましいが、薄くすると含有さ
せることのできる薬物量が少なくなるという観点から、
本発明の含水性皮膚外用貼付剤に於いて、粘着剤層の厚
さは100〜1000μm、更に好ましくは100〜8
00μmが好適である。
The thickness of the pressure-sensitive adhesive layer is particularly important in the hydrous external skin patch of the present invention. Generally, when the thickness of the pressure-sensitive adhesive layer is increased, the pressure-sensitive adhesive force is increased, but on the contrary, the flexibility is lowered, the discomfort at the time of sticking is increased, and the pressure-sensitive adhesive layer is easily removed. In the conventionally known hydrous molded poultices, the adhesive strength of the adhesive itself is relatively weak, and it is necessary to have a certain thickness to expect a certain degree of adhesive strength. Therefore, the problem of falling off when sticking is inevitable. It was According to the hydrous external skin patch of the present invention comprising a tackifying resin as an essential component, the adhesive layer has sufficient adhesive force even if the adhesive layer is thin, and therefore from the point of the invention of improving usability. If so, it is preferable to make it as thin as possible, but from the viewpoint of reducing the amount of drug that can be contained,
In the hydrous external skin patch of the present invention, the pressure-sensitive adhesive layer has a thickness of 100 to 1000 μm, more preferably 100 to 8 μm.
00 μm is preferable.

【0014】本発明の粘着剤組成物中には他にゼラチ
ン、カルボキシメチルセルロース、メチルセルロース、
ポリビニールアルコール、ポリアクリル酸及びこれらの
金属塩等の水溶性高分子、グリセリン、ソルビトール、
ポリエチレングリコール、プロピレングリコール、1,
3−ブチレングリコール等の多価アルコール、酸化亜
鉛、合成ケイ酸アルミニウム、水酸化アルミニウムゲル
等の金属架橋剤を必要に応じて適宜組み合わせて配合す
ることができる。
In the pressure-sensitive adhesive composition of the present invention, gelatin, carboxymethyl cellulose, methyl cellulose,
Water-soluble polymers such as polyvinyl alcohol, polyacrylic acid and their metal salts, glycerin, sorbitol,
Polyethylene glycol, propylene glycol, 1,
A polyhydric alcohol such as 3-butylene glycol, a zinc oxide, a metal cross-linking agent such as a synthetic aluminum silicate, and an aluminum hydroxide gel may be appropriately combined and blended as necessary.

【0015】水溶性高分子の配合量としては通常、本粘
着剤組成物の5〜20重量%であり、少な過ぎると得ら
れる組成物の強度が弱く、貼付した時にダレ易くなり、
多過ぎると得られる組成物の強度が強過ぎ製造に困難を
きたす。多価アルコールの配合量としては通常、本粘着
剤組成物の15〜60重量%であり、少な過ぎると保水
性が不足し、貼付時の体温によって水分が揮散し易く、
長時間の貼付に耐えないし、多過ぎると他成分の配合が
困難となる。金属架橋剤の配合量としては通常、本粘着
剤組成物の0.01〜10重量%であり、少な過ぎると
架橋が弱過ぎて貼付剤としての形態を保つことができな
いし、多過ぎると架橋が強過ぎて製造に困難をきたす。
The amount of the water-soluble polymer compounded is usually 5 to 20% by weight of the present pressure-sensitive adhesive composition. If the amount is too small, the strength of the resulting composition will be weak and the composition will easily drip when applied.
If the amount is too large, the strength of the resulting composition is too strong, which causes difficulty in production. The content of the polyhydric alcohol is usually 15 to 60% by weight of the present pressure-sensitive adhesive composition, and when the amount is too small, the water retention is insufficient, and the water easily volatilizes due to the body temperature during application,
It cannot withstand application for a long time, and if it is too much, it becomes difficult to mix other components. The content of the metal cross-linking agent is usually 0.01 to 10% by weight of the present pressure-sensitive adhesive composition, and if it is too small, the cross-linking is too weak to maintain the form as a patch, and if it is too large, the cross-linking is performed. Is too strong and causes manufacturing difficulties.

【0016】更に、本発明の粘着剤組成物中には、有機
酸、有機塩基、無機酸、無機塩基等のpH調整剤、エデ
ト酸ナトリウム、ジブチルヒドロキシトルエン、亜硫酸
水素ナトリウム等の安定化剤、パラオキシ安息香酸エス
テル類、ベンジルアルコール、チモール等の防腐剤、ク
ロタミトン、ベンジルアルコール、脂肪酸エステル類等
の薬物溶解剤、ポリソルベート類、ショ糖脂肪酸エステ
ル類、ポリオキシエチレンアルキルエーテル類等の界面
活性剤等を適宜配合することもできる。
Further, in the pressure-sensitive adhesive composition of the present invention, a pH adjusting agent such as an organic acid, an organic base, an inorganic acid or an inorganic base, a stabilizer such as sodium edetate, dibutylhydroxytoluene or sodium bisulfite, Paraoxybenzoic acid esters, preservatives such as benzyl alcohol, thymol, drug dissolving agents such as crotamiton, benzyl alcohol, fatty acid esters, surfactants such as polysorbates, sucrose fatty acid esters, polyoxyethylene alkyl ethers, etc. Can also be appropriately mixed.

【0017】また本発明品を医薬としての使用に供する
ためにサリチル酸メチル、サリチル酸グリコール、カン
フル、メントール、トウガラシエキス、ノニル酸ワニリ
ルアミド等の局所刺激剤、酢酸トコフェロール、ニコチ
ン酸トコフェロール等の抹梢血流改善剤、ジフェンヒド
ラミン、マレイン酸クロルフェニラミン、塩酸イソチペ
ンジル等の抗ヒスタミン剤、トウキ、オウバク、サンシ
シ、アルニカ、西洋トチノミ等の消炎性生薬のエキスや
粉末、グリチルレチン酸、インドメタシン、ピロキシカ
ム、ケトプロフェン、フルルビプロフェン、フェルビナ
ク等の非ステロイド性消炎鎮痛剤、プレドニゾロン、ハ
イドロコルチゾン、デキサメタゾン、フルオシノロンア
セトニド等の外用ステロイド剤、クロタミトン等の鎮痒
剤、リドカイン、ジブカイン等の局所麻酔剤、グルコン
酸クロルヘキシジン、塩化セチルピリジニウム、塩化ベ
ンザルコニウム等の殺菌消毒剤等を配合することができ
る。
In order to use the product of the present invention as a medicine, a topical stimulant such as methyl salicylate, glycol salicylate, camphor, menthol, capsicum extract, vanillylamide nonylate, tocopherol acetate, tocopherol nicotinate, etc., peripheral blood flow. Improvers, antihistamines such as diphenhydramine, chlorpheniramine maleate, isothipendyl hydrochloride, etc., extracts and powders of anti-inflammatory herbal medicines such as Touki, Oataku, Sanshishi, Arnica, horse mackerel, glycyrrhetinic acid, indomethacin, piroxicam, ketoprofen, flurbiprofen , Nonsteroidal anti-inflammatory analgesics such as felbinac, external steroids such as prednisolone, hydrocortisone, dexamethasone, fluocinolone acetonide, antipruritics such as crotamiton, lidocaine, Local anesthetics such as Bukain, chlorhexidine gluconate, cetylpyridinium chloride, can be formulated disinfectant such as benzalkonium chloride.

【0018】本発明の含水性皮膚外用貼付剤は、水、溶
解剤に溶解した粘着付与性樹脂及び吸油性無機性粉末を
必須の構成成分として含有する、均一に混合して製した
粘着剤組成物を平滑な担持体上に展延塗布し、厚さ10
0〜1000μmの均一な粘着剤層を形成し、剥離ライ
ナーフィルムで被覆するか、平滑なライナーフィルム上
に先の粘着剤層を厚さ100〜1000μmに形成して
担持体で被覆するかして得られる。
The hydrous external skin patch of the present invention contains water, a tackifying resin dissolved in a solubilizer, and an oil-absorbing inorganic powder as essential constituents, and is prepared by uniformly mixing them. Spread the material on a smooth carrier and apply a thickness of 10
A uniform pressure-sensitive adhesive layer having a thickness of 0 to 1000 μm is formed and coated with a release liner film, or the pressure-sensitive adhesive layer is formed on a smooth liner film to a thickness of 100 to 1000 μm and coated with a carrier. can get.

【0019】使用される担持体としては、本発明品の如
き含水性粘着剤層の場合にはその投錨性の観点から、織
布、不織布が良好であるが、粘着剤層と反対側にポリエ
チレン、塩化ビニル等のプラスチック膜を形成させた複
合フィルムも良好に使用される。
In the case of a water-containing pressure-sensitive adhesive layer such as the product of the present invention, a woven fabric or a non-woven fabric is preferable as the carrier to be used from the viewpoint of anchoring property, but polyethylene is provided on the side opposite to the pressure-sensitive adhesive layer. A composite film formed with a plastic film such as vinyl chloride is also favorably used.

【0020】これら担持体は透湿性とすることも非透湿
性とすることも可能であるが、本発明の趣旨、皮膚安全
性の観点からすれば透湿性とすることが望ましい。また
これら担持体は伸縮性とすることも非伸縮性とすること
もできるが、肘、膝等の屈曲部位への使用を考慮すれば
伸縮性とすることが望ましい。
Although these carriers can be moisture-permeable or moisture-impermeable, it is preferable that they be moisture-permeable from the point of the present invention and the viewpoint of skin safety. Further, these carriers may be stretchable or non-stretchable, but it is preferable that they be stretchable in consideration of use in a flexed portion such as an elbow and a knee.

【0021】使用される剥離ライナーフィルムとして
は、ポリエチレン、ポリプロピレン、ポリエチレンテレ
フタレート、紙等通常使用されるものが適宜使用される
が、剥離性を調節するために必要に応じてシリコーン処
理を施したり、エンボス処理を施したりすることもでき
る。
As the release liner film to be used, those usually used such as polyethylene, polypropylene, polyethylene terephthalate and paper can be appropriately used. If necessary, a silicone treatment may be carried out to adjust the release property, It can also be embossed.

【0022】[0022]

【発明の効果】従来公知の含水性成型パップ剤に於いて
は皮膚刺激といった問題はないものの、粘着剤層の厚さ
を薄くした時には粘着力が低下し、実質上貼付剤として
の用をなさなくなるのが通例であり、薄くて、しかも十
分な粘着力を有する含水性成型パップ剤を提供すること
は不可能であった。一方、従来公知の実質的に無水の硬
膏剤、テープ剤にあっては粘着剤層の厚さを薄くしても
十分な粘着力を付与することは可能であるが、皮膚刺激
といった問題は避け難かった。従って従来技術によって
は皮膚刺激のない、しかも薄くて十分な粘着力を有し貼
付時に脱落することのない、使用性にも優れた皮膚外用
貼付剤を提供することは不可能であった。
EFFECTS OF THE INVENTION Although there is no problem of skin irritation in hitherto known hydrous molded poultices, when the thickness of the pressure-sensitive adhesive layer is reduced, the tackiness decreases, and thus it is practically not used as a patch. It is usually lost, and it has been impossible to provide a water-containing molded poultice that is thin and has sufficient adhesive strength. On the other hand, in the case of conventionally known substantially anhydrous plasters and tapes, it is possible to give sufficient adhesive force even if the thickness of the adhesive layer is reduced, but avoid the problem of skin irritation. It was difficult. Therefore, it has been impossible to provide a skin external patch that is not irritating to the skin, is thin and has sufficient adhesive force, and does not fall off during application, and is excellent in usability by the conventional techniques.

【0023】粘着付与性樹脂を含水性基剤中に合理的に
配合した本発明の含水性皮膚外用貼付剤によれば、粘着
剤層の厚さを薄くしても十分な粘着力を有する製剤が可
能であり、それ自身、従来の含水性成型パップ剤と同程
度の水を含有しているため皮膚刺激といった問題もな
い。
According to the hydrous external skin patch of the present invention in which a tackifying resin is rationally blended in a hydrous base, a preparation having sufficient adhesive strength even if the thickness of the adhesive layer is reduced. Since it contains the same amount of water as the conventional hydrous molded poultice, it does not cause skin irritation.

【0024】すなわち、本発明によれば、十分な柔軟性
を有し、貼付時に違和感がなく、脱落することもなく、
従って固定のための他の補助的手段も要せず、また、か
ぶれ症状の発現もなく、剥離時に角質層を損傷すること
もない、極めて優れた使用性を有する理想的な皮膚外用
貼付剤を得ることができる。以下、実施例を示し本発明
を具体的に説明する。なお本発明はこれらの実施例に限
定されるものではない。
That is, according to the present invention, it has sufficient flexibility, does not feel uncomfortable when applied, and does not fall off,
Therefore, an ideal external patch for external use having extremely excellent usability, which does not require other auxiliary means for fixation, does not cause rash symptoms, and does not damage the stratum corneum during peeling Obtainable. Hereinafter, the present invention will be specifically described with reference to examples. The present invention is not limited to these examples.

【0025】[0025]

【実施例】【Example】

実施例1〜8 Examples 1-8

【0026】[0026]

【表1】表1:粘着剤組成物の配合組成(単位:g) 実施例No. 1 2 3 4 5 6 7 8 成 分 エステルガム* 2.5 2.5 5.0 5.0 7.5 7.5 15.0 15.0 流動パラフィン 0.5 1.25 1.0 2.5 1.5 3.75 3.0 7.5 ポリアクリル酸 5 5 5 5 5 5 5 5 ナトリウム 乾燥水酸化アルミ 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 ニウムゲル 乳酸 1 1 1 1 1 1 1 1 濃グリセリン 30 30 30 30 30 30 30 30 D−ソルビトール液 15 15 15 15 15 15 15 15 精製水 35.7 34.95 32.7 31.2 29.7 27.45 20.7 16.2 カルボキシメチルセル 3 3 3 3 3 3 3 3 ロースナトリウム カオリン 5 5 5 5 5 5 5 5 精製ゼラチン 2 2 2 2 2 2 2 2 *KE−311:荒川化学工業(株)製[Table 1] Table 1: Composition of the adhesive composition (unit: g) Example No. 1 2 3 4 5 6 7 8 Component ester gum * 2.5 2.5 5.0 5.0 7.5 7.5 15.0 15.0 Liquid paraffin 0.5 1.25 1.0 2.5 1.5 3.75 3.0 7.5 Polyacrylic acid 5 5 5 5 5 5 5 5 Sodium dry aluminum hydroxide 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Nigel lactic acid 1 1 1 1 1 1 1 1 Concentrated glycerin 30 30 30 30 30 30 30 30 D- Sorbitol solution 15 15 15 15 15 15 15 15 Purified water 35.7 34.95 32.7 31.2 29.7 27.45 20.7 16.2 Carboxymethyl cell 3 3 3 3 3 3 3 3 3 Sodium sucrose Kaolin 5 5 5 5 5 5 5 5 5 Purified gelatin 2 2 2 2 2 2 2 2 2 * KE-311: Arakawa Chemical Industry Co., Ltd.

【0027】表1に示す組成で、ポリアクリル酸ナトリ
ウム、乾燥水酸化アルミニウムゲル、乳酸、濃グリセリ
ン、D−ソルビトール酸、カルボキシメチルセルロース
ナトリウム、カオリン、精製ゼラチン、精製水を混和
し、これに流動パラフィンに溶解したエステルガムを添
加、撹拌機にて全質均等となるまで撹拌して得た組成物
を厚さ500μmとなるようにポリエチレンテレフタレ
ート製の剥離ライナーフィルム上に展延塗布し、ポリエ
ステル製の伸縮性織布で被覆して本発明の皮膚外用貼付
剤を得る。
In the composition shown in Table 1, sodium polyacrylate, dried aluminum hydroxide gel, lactic acid, concentrated glycerin, D-sorbitol acid, sodium carboxymethyl cellulose, kaolin, purified gelatin and purified water were mixed, and liquid paraffin was added to the mixture. The ester gum dissolved in the above was added, and the composition obtained by stirring with a stirrer until the quality became uniform was spread-coated on a release liner film made of polyethylene terephthalate to a thickness of 500 μm. The skin external patch of the present invention is obtained by coating with a stretchable woven fabric.

【0028】実施例9 実施例6に於いて粘着剤層の厚さを750μmとした他
は同様に製した。 実施例10 実施例6に於いて粘着剤層の厚さを1000μmとした
他は同様に製した。 実施例11 実施例6に於いて粘着剤層の厚さを100μmとした他
は同様に製した。
Example 9 The procedure of Example 6 was repeated except that the pressure-sensitive adhesive layer had a thickness of 750 μm. Example 10 The same procedure as in Example 6 was carried out except that the pressure-sensitive adhesive layer had a thickness of 1000 μm. Example 11 The same procedure as in Example 6 was carried out except that the thickness of the pressure-sensitive adhesive layer was 100 μm.

【0029】実施例12 実施例5に於いてエステルガムをKE−311(荒川化
学工業(株)製)からAAG(荒川化学工業(株)製)
に替える他は同様に製した。 実施例13 実施例5に於いてエステルガムをKE−311(荒川化
学工業(株)製)からDS−90S(ハリマ化成工業
(株)製)に替える他は同様に製した。
Example 12 In Example 5, the ester gum was changed from KE-311 (Arakawa Chemical Industry Co., Ltd.) to AAG (Arakawa Chemical Industry Co., Ltd.).
It was made in the same manner except that it was replaced with. Example 13 The same procedure as in Example 5 was performed except that the ester gum was changed from KE-311 (manufactured by Arakawa Chemical Industry Co., Ltd.) to DS-90S (manufactured by Harima Chemicals Co., Ltd.).

【0030】実施例14 実施例5に於いて粘着付与性樹脂の溶解剤を、流動パラ
フィンから中鎖脂肪酸トリグリセライドであるトリエス
ターF−810(日光ケミカルズ(株)製)に替える他
は同様に製した。 実施例15 実施例5に於いて粘着付与性樹脂の溶解剤を、流動パラ
フィンからゴマ油(日局)に替える他は同様に製した。
Example 14 The procedure of Example 5 was repeated except that the solvent for the tackifying resin was changed from liquid paraffin to medium-chain fatty acid triglyceride Triester F-810 (manufactured by Nikko Chemicals Co., Ltd.). did. Example 15 In the same manner as in Example 5, except that the solvent for the tackifying resin was changed from liquid paraffin to sesame oil (JP), the same production was carried out.

【0031】実施例16 実施例5に於いて粘着付与性樹脂の溶解剤を、流動パラ
フィンから中鎖脂肪酸トリグリセライドであるココナー
ドMK(花王(株)製)に替える他は同様に製した。
Example 16 The procedure of Example 5 was repeated except that the solvent for the tackifying resin was changed from liquid paraffin to Coconade MK (Kao Corporation), which is a medium-chain fatty acid triglyceride.

【0032】実施例17 ポリアクリル酸ナトリウム5g、酸化亜鉛1g、リン酸
1g、濃グリセリン30g、D−ソルビトール液15
g、カルボキシメチルセルロースナトリウム3g、カオ
リン5g、精製ゼラチン2g、精製水29gを混和し、
これに流動パラフィン1.5gに溶解したエステルガム
(KE−311:荒川化学(株)製)7.5gを添加、
撹拌機にて全質均等となるまで撹拌して得た組成物を以
下実施例1〜8と同様に製した。
Example 17 Sodium polyacrylate 5 g, zinc oxide 1 g, phosphoric acid 1 g, concentrated glycerin 30 g, D-sorbitol liquid 15
g, sodium carboxymethylcellulose 3g, kaolin 5g, purified gelatin 2g, purified water 29g,
To this, 7.5 g of ester gum (KE-311: manufactured by Arakawa Chemical Co., Ltd.) dissolved in 1.5 g of liquid paraffin was added,
Compositions obtained by stirring with a stirrer until the quality became uniform were produced in the same manner as in Examples 1 to 8 below.

【0033】実施例18 ポリアクリル酸ナトリウム5g、合成ケイ酸アルミニウ
ム2g、メタリン酸ナトリウム0.3g、濃グリセリン
30g、D−ソルビトール液15g、カオリン7g、精
製ゼラチン2g、精製水29.7gを混和し、これに流
動パラフィン1.5gに溶解したエステルガム(KE−
311:荒川化学(株)製)7.5gを添加、撹拌機に
て全質均等となるまで撹拌して得た組成物を以下実施例
1〜8と同様に製した。
Example 18 5 g of sodium polyacrylate, 2 g of synthetic aluminum silicate, 0.3 g of sodium metaphosphate, 30 g of concentrated glycerin, 15 g of D-sorbitol solution, 7 g of kaolin, 2 g of purified gelatin, and 29.7 g of purified water were mixed. , An ester gum dissolved in 1.5 g of liquid paraffin (KE-
311: Arakawa Chemical Co., Ltd.) (7.5 g) was added, and a composition obtained by stirring with a stirrer until the quality became uniform was produced in the same manner as in Examples 1 to 8 below.

【0034】比較例1 ポリアクリル酸ナトリウム5g、乾燥水酸化アルミニウ
ムゲル0.3g、乳酸1g、濃グリセリン30g、D−
ソルビトール液15g、カルボキシメチルセルロースナ
トリウム3g、カオリン5g、精製ゼラチン2g、精製
水38.7gを混和し、撹拌機にて全質均等となるまで
撹拌して得た組成物を厚さ100μmとなるようにポリ
エチレンテレフタレート製の剥離ライナーフィルム上に
展延し、ポリエステル製の伸縮性織布で被覆して比較例
1を得た。
Comparative Example 1 Sodium polyacrylate 5 g, dried aluminum hydroxide gel 0.3 g, lactic acid 1 g, concentrated glycerin 30 g, D-
15 g of sorbitol liquid, 3 g of sodium carboxymethyl cellulose, 5 g of kaolin, 2 g of purified gelatin, and 38.7 g of purified water were mixed, and the mixture was stirred with a stirrer until the quality became uniform, so that the composition had a thickness of 100 μm. Comparative Example 1 was obtained by spreading on a release liner film made of polyethylene terephthalate and covering with a stretchable woven fabric made of polyester.

【0035】比較例2 粘着剤層の厚さを500μmとした他は比較例1と同様
にして比較例2を得た。 比較例3 粘着剤層の厚さを1000μmとした他は比較例1と同
様にして比較例3を得た。 比較例4 粘着剤層の厚さを1500μmとした他は比較例1と同
様にして比較例4を得た。
Comparative Example 2 Comparative Example 2 was obtained in the same manner as Comparative Example 1 except that the pressure-sensitive adhesive layer had a thickness of 500 μm. Comparative Example 3 Comparative Example 3 was obtained in the same manner as Comparative Example 1 except that the pressure-sensitive adhesive layer had a thickness of 1000 μm. Comparative Example 4 Comparative Example 4 was obtained in the same manner as Comparative Example 1 except that the thickness of the pressure-sensitive adhesive layer was 1500 μm.

【0036】比較例5 実施例17からエステルガム、流動パラフィンを除い
て、他は同様に製して比較例5を得た。 比較例6 実施例18からエステルガム、流動パラフィンを除い
て、他は同様に製して比較例6を得た。 比較例7〜9 実施例5,17,18からカオリンを除き、その分量を
水で補い、他は同様に製してそれぞれ比較例7,8,9
を得た。
Comparative Example 5 Comparative Example 5 was prepared in the same manner as in Example 17, except that the ester gum and liquid paraffin were removed. Comparative Example 6 Comparative Example 6 was obtained in the same manner as in Example 18, except that the ester gum and liquid paraffin were removed. Comparative Examples 7 to 9 Comparative Examples 7, 8 and 9 were prepared by removing kaolin from Examples 5, 17 and 18, supplementing the amount with water, and otherwise making the same.
Got

【0037】試験例1 〈粘着力試験〉実施例1〜18、比較例1〜6、市販の
テープ剤(テープ剤(A)、(B)及び(C))及び市
販のパップ剤(パップ剤(A)及び(B))を用いて5
00g/cm2・min の負荷後のステンレス板よりの
水平剥離荷重を測定した。その結果を表2及び表3に示
す。
Test Example 1 <Adhesion Test> Examples 1 to 18, Comparative Examples 1 to 6, commercially available tape preparations (tape preparations (A), (B) and (C)) and commercially available poultice preparations (puppet preparations). 5 using (A) and (B))
The horizontal peeling load from the stainless steel plate after a load of 00 g / cm 2 · min was measured. The results are shown in Tables 2 and 3.

【0038】試験例2 〈ラット皮膚損傷試験〉実施例1〜18、比較例1〜
6、市販のテープ剤(テープ剤(A)、(B)及び
(C))及び市販のパップ剤(パップ剤(A)及び
(B))を用いてラット皮膚損傷試験を実施した。 試験方法:各検体を2×2cm2 に裁断し、除毛したラ
ット腹部皮膚に貼付して直ちに剥離する操作を同一部位
で繰り返し、皮膚角質層が剥離されるまでの貼付回数を
測定する。但し20回でも剥離しなかった場合には「剥
離なし」と判定した。その結果を表4及び表5に示す。
Test Example 2 <Rat Skin Damage Test> Examples 1 to 18 and Comparative Examples 1 to 1
6. A rat skin damage test was carried out using commercially available tape preparations (tape preparations (A), (B) and (C)) and commercially available poultice preparations (Pap preparations (A) and (B)). Test method: Each sample is cut into 2 × 2 cm 2, and the operation of sticking to the shaved rat abdominal skin and immediately peeling is repeated at the same site, and the number of times of sticking until the stratum corneum is peeled off is measured. However, when the peeling did not occur even after 20 times, it was judged as "no peeling". The results are shown in Tables 4 and 5.

【0039】試験例3 〈24時間パッチテスト〉実施例2,6,8,12,1
3,15,17,18,市販のテープ剤(テープ剤
(A)、(B)及び(C))及び市販のパップ剤(パッ
プ剤(A)及び(B))を用いて健常成人でパッチテス
トを実施した。 試験方法:1.5cm×1.5cmに裁断した各検体を
健常成人13名の上腕屈側部位に貼付し、エラストポア
テープ(ニチバン(株))で被覆固定し、24時間後に
除去した。除去後1及び24時間目の皮膚の状態を観察
し、下記の基準で採点し、数1に従って皮膚刺激指数を
求めた。 採点基準:無反応 0 点 わずかな紅斑 0.5点 明らかな紅斑 1 点 紅斑+浮腫または丘疹 2 点 紅斑+浮腫+丘疹、小水疱 3 点 大水疱、壊死 4 点 その結果を表6に示す。
Test Example 3 <24-hour patch test> Examples 2, 6, 8, 12, 1
3,15,17,18, Patches on healthy adults using commercially available tape preparations (tape preparations (A), (B) and (C)) and commercially available poultice preparations (Pap preparations (A) and (B)) The test was conducted. Test method: Each sample cut into 1.5 cm × 1.5 cm was attached to the upper arm flexion site of 13 healthy adults, covered and fixed with elastpore tape (Nichiban Co., Ltd.), and removed after 24 hours. The condition of the skin at 1 and 24 hours after the removal was observed and scored according to the following criteria, and the skin irritation index was calculated according to the formula 1. Scoring criteria: no reaction 0 point slight erythema 0.5 point clear erythema 1 point erythema + edema or papule 2 points erythema + edema + papule, vesicle 3 points blister, necrosis 4 points The results are shown in Table 6.

【0040】[0040]

【数1】 [Equation 1]

【0041】試験例4 〈屈曲伸展部位貼付試験〉実施例2,6,8,10,1
1,12,13,15,17,18,比較例1〜6、市
販のテープ剤(テープ剤(A)、(B)及び(C))及
び市販のパップ剤(パップ剤(A)及び(B))を用い
て健常成人の屈曲伸展部位での貼付試験を実施した。 試験方法:7cm×10cmに裁断した検体を健常成人
の膝に伸展時に貼付して直ちに強く膝を屈曲した時の状
態を観察した。 判定:剥れる × 一部剥れる △ 剥れない ○ その結果を表7に示す。
Test Example 4 <Flex extension site sticking test> Examples 2, 6, 8, 10, 1
1, 12, 13, 15, 17, 18, Comparative Examples 1 to 6, commercially available tape agents (tape agents (A), (B) and (C)) and commercially available poultice agents (poultice agents (A) and ( B)) was used to carry out a patch test on a flexion and extension site of a healthy adult. Test method: A sample cut into 7 cm x 10 cm was attached to the knee of a healthy adult during extension, and the state when the knee was immediately bent strongly was observed. Judgment: peeling off × partly peeling off Δnot peeling off ○ The results are shown in Table 7.

【0042】試験例5 〈保存安定性試験〉実施例5,17,18,比較例7,
8,9を用いて保存安定性試験を実施した。 試験方法:各検体をアルミ袋に入れ気密密封後、50℃
の恒温機中に保存し、一週間後の支持体側への油成分の
しみ出しの状態を観察した。 判定:しみ出し有 × しみ出し無 ○ その結果を表8に示す。
Test Example 5 <Storage stability test> Examples 5, 17, 18 and Comparative Example 7,
A storage stability test was carried out using Nos. 8 and 9. Test method: Each sample is placed in an aluminum bag and hermetically sealed at 50 ° C.
The sample was stored in an incubator of No. 1 and the state of exudation of the oil component on the support side after one week was observed. Judgment: With bleeding out × Without bleeding out ○ The results are shown in Table 8.

【0043】[0043]

【表2】 [Table 2]

【0044】[0044]

【表3】 [Table 3]

【0045】[0045]

【表4】 [Table 4]

【0046】[0046]

【表5】 [Table 5]

【0047】[0047]

【表6】 [Table 6]

【0048】[0048]

【表7】 [Table 7]

【0049】[0049]

【表8】表8:保存安定性試験結果 実 施 例 比 較 例 検体 No. 5 17 18 7 8 9 判 定 ○ ○ ○ × × × [Table 8] Table 8: Results of storage stability test Example ratio Comparative sample No. 5 17 18 7 8 9 Judgment ○ ○ ○ × × ×

【0050】以上の結果によれば、粘着付与性樹脂を配
合していない比較例、及び市販パップ剤ではラット皮膚
損傷試験及び24時間パッチテストに於いては良好な結
果を示すものの、その粘着力は小さく、しかも粘着剤層
の厚さによって大きく影響を受け、薄いものでは殆んど
貼付剤としての用をなさないことが判る。
According to the above results, the comparative example not containing the tackifying resin and the commercially available poultice showed good results in the rat skin damage test and the 24-hour patch test, but the tackiness It can be seen that is small, and is greatly affected by the thickness of the pressure-sensitive adhesive layer, and that a thin one is almost useless as a patch.

【0051】市販テープ剤では強い粘着力がうかがわれ
るが、ラット皮膚損傷試験に於いてはいずれも3〜4回
で皮膚角質層が剥離され、24時間パッチテストに於い
ても皮膚刺激指数が大きく、安全性の面で問題を有する
ことがうかがわれる。一方、本発明の実施例に於いては
いずれも良好な粘着性を有し、また剥離時に皮膚角質層
を損傷することもなく皮膚刺激もない。
The commercially available tapes show strong adhesiveness, but in the rat skin damage test, the stratum corneum was peeled off 3 to 4 times, and the skin irritation index was also found in the 24 hour patch test. It seems that there is a big problem in terms of safety. On the other hand, all of the examples of the present invention have good adhesiveness and do not damage the stratum corneum of the skin during peeling or cause skin irritation.

【0052】このことから本発明が従来技術では不可能
であった理想的な皮膚外用貼付剤を提供するものである
ことが判る。以下、本発明に基づく製剤例を示す。
From this, it is understood that the present invention provides an ideal external patch for skin, which was impossible with the prior art. Hereinafter, formulation examples based on the present invention will be shown.

【0053】 製剤例1 サリチル酸メチル、1−メントール等含有貼付剤 サリチル酸メチル 1.5g 1−メントール 0.5g エステルガム 7.5g 流動パラフィン 1.5g ポリアクリル酸ナトリウム 5.0g 乾燥水酸化アルミニウムゲル 0.3g 乳酸 1.0g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 32.7g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 1 Patch containing methyl salicylate, 1-menthol, etc. Methyl salicylate 1.5 g 1-Menthol 0.5 g Ester gum 7.5 g Liquid paraffin 1.5 g Sodium polyacrylate 5.0 g Dry aluminum hydroxide gel 0 .3 g Lactic acid 1.0 g Concentrated glycerin 30 g D-sorbitol solution 15 g Purified water 32.7 g Carboxymethyl cellulose sodium 3.0 g Purified gelatin 2.0 g Total amount 100 g

【0054】 製剤例2 サリチル酸エチレングリコール、1−メントール等含有貼付剤 サリチル酸エチレングリコール 1.5g 1−メントール 0.5g ハッカ油 1.0g エステルガム 7.5g 流動パラフィン 1.5g ポリアクリル酸ナトリウム 5.0g 合成ケイ酸アルミニウム 2.0g メタリン酸ナトリウム 0.3g 1N−塩酸 3.5g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 27.2g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 2 Patch containing ethylene glycol salicylate, 1-menthol, etc. Ethylene glycol salicylate 1.5 g 1-menthol 0.5 g Mint oil 1.0 g Ester gum 7.5 g Liquid paraffin 1.5 g Sodium polyacrylate 5. 0 g Synthetic aluminum silicate 2.0 g Sodium metaphosphate 0.3 g 1N-hydrochloric acid 3.5 g Concentrated glycerin 30 g D-sorbitol solution 15 g Purified water 27.2 g Carboxymethylcellulose sodium 3.0 g Purified gelatin 2.0 g Total amount 100 g

【0055】 製剤例3 フルオシノロンアセトニド含有貼付剤 フルオシノロンアセトニド 0.01g エステルガム 7.5g 流動パラフィン 1.5g ポリアクリル酸ナトリウム 3.5g 酸化亜鉛 0.5g リン酸 1.0g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 35.99g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 3 Patch containing fluocinolone acetonide Fluocinolone acetonide 0.01 g Ester gum 7.5 g Liquid paraffin 1.5 g Sodium polyacrylate 3.5 g Zinc oxide 0.5 g Phosphoric acid 1.0 g Concentrated Glycerin 30 g D-sorbitol solution 15 g Purified water 35.99 g Sodium carboxymethyl cellulose 3.0 g Purified gelatin 2.0 g Total amount 100 g

【0056】 製剤例4 オウバク等含有貼付剤 オウバク末 2.0g 酢酸dl−α−トコフェロール 0.3g ジフェンヒドラミン 0.1g エステルガム 7.5g ココナードMK 1.5g ポリアクリル酸ナトリウム 5.0g 乾燥水酸化アルミニウムゲル 0.2g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 33.4g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 4 Patch containing oat, etc. Oat powder 2.0 g Acetate dl-α-tocopherol 0.3 g Diphenhydramine 0.1 g Ester gum 7.5 g Coconard MK 1.5 g Sodium polyacrylate 5.0 g Dry aluminum hydroxide Gel 0.2 g Concentrated glycerin 30 g D-sorbitol solution 15 g Purified water 33.4 g Carboxymethylcellulose sodium 3.0 g Purified gelatin 2.0 g Total amount 100 g

【0057】 製剤例5 リドカイン含有貼付剤 リドカイン 2.5g エステルガム 7.5g 流動パラフィン 1.5g ポリアクリル酸ナトリウム 5.0g 乾燥水酸化アルミニウム 0.3g 酒石酸 0.5g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 32.7g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 5 Lidocaine-containing patch Lidocaine 2.5 g Ester gum 7.5 g Liquid paraffin 1.5 g Sodium polyacrylate 5.0 g Dry aluminum hydroxide 0.3 g Tartaric acid 0.5 g Concentrated glycerin 30 g D-sorbitol liquid 15 g Purified water 32.7 g Sodium carboxymethyl cellulose 3.0 g Purified gelatin 2.0 g Total amount 100 g

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成5年1月11日[Submission date] January 11, 1993

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0005[Name of item to be corrected] 0005

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0005】[0005]

【発明が解決しようとする課題】従来公知の含水性成型
パップ剤に於いては皮膚刺激といった問題はないもの
の、粘着剤層の厚さを薄くした時には粘着力が低下し、
実質上貼付剤としての用をなさなくなるのが通例であ
り、薄くて、しかも十分な粘着力を有する含水性成型パ
ップ剤を提供することは不可能であった。一方、公知の
硬膏剤、テープ剤にあっては粘着剤層の厚さを薄くして
も十分な粘着力を付与することは可能であるが皮膚刺激
といった問題は避け難かった。従って従来技術によって
は皮膚刺激のない、しかも薄くて十分な粘着力を有し貼
付時に脱落することのない、使用性にも優れた皮膚外用
貼付剤を提供することは不可能であった。
Although there are no problems such as skin irritation in the conventionally known hydrous molded poultices, when the thickness of the pressure-sensitive adhesive layer is reduced, the tackiness decreases.
It is customary that it will no longer be practically used as a patch , and it has been impossible to provide a water-containing molded poultice that is thin and has sufficient adhesive strength. On the other hand, in the case of known plasters and tapes, it is possible to give a sufficient adhesive force even if the thickness of the adhesive layer is thin, but it is difficult to avoid the problem of skin irritation. Therefore, it has been impossible to provide a skin external patch that is not irritating to the skin, is thin and has sufficient adhesive force, and does not fall off during application, and is excellent in usability by the conventional techniques.

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0017[Correction target item name] 0017

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0017】また本発明品を医薬としての使用に供する
ためにサリチル酸メチル、サリチル酸グリコール、カン
フル、メントール、トウガラシエキス、ノニル酸ワニリ
ルアミド等の局所刺激剤、酢酸トコフェロール、ニコチ
ン酸トコフェロール等の末梢血流改善剤、ジフェンヒド
ラミン、マレイン酸クロルフェニラミン、塩酸イソチペ
ンジル等の抗ヒスタミン剤、トウキ、オウバク、サンシ
シ、アルニカ、西洋トチノミ等の消炎性生薬のエキスや
粉末、グリチルレチン酸、インドメタシン、ピロキシカ
ム、ケトプロフェン、フルルビプロフェン、フェルビナ
ク等の非ステロイド性消炎鎮痛剤、プレドニゾロン、ハ
イドロコルチゾン、デキサメタゾン、フルオシノロンア
セトニド等の外用ステロイド剤、クロタミトン等の鎮痒
剤、リドカイン、ジブカイン等の局所麻酔剤、グルコン
酸クロルヘキシジン、塩化セチルピリジニウム、塩化ベ
ンザルコニウム等の殺菌消毒剤等を配合することができ
る。
Further, in order to use the product of the present invention as a medicine, a local stimulant such as methyl salicylate, glycol salicylate, camphor, menthol, capsicum extract, vanillylamide nonylate, tocopherol acetate and tocopherol nicotinate improve peripheral blood flow. Agents, antihistamines such as diphenhydramine, chlorpheniramine maleate, isothipendyl hydrochloride, etc., extracts and powders of anti-inflammatory herbal medicines such as Touki, Oataku, Sanshishi, Arnica, horse mackerel, glycyrrhetinic acid, indomethacin, piroxicam, ketoprofen, flurbiprofen, Non-steroidal anti-inflammatory analgesics such as felbinac, prednisolone, hydrocortisone, dexamethasone, external steroids such as fluocinolone acetonide, antipruritics such as crotamiton, lidocaine, Local anesthetics such as Bukain, chlorhexidine gluconate, cetylpyridinium chloride, can be formulated disinfectant such as benzalkonium chloride.

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0027[Name of item to be corrected] 0027

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0027】表1に示す組成で、ポリアクリル酸ナトリ
ウム、乾燥水酸化アルミニウムゲル、乳酸、濃グリセリ
ン、D−ソルビトール液、カルボキシメチルセルロース
ナトリウム、カオリン、精製ゼラチン、精製水を混和
し、これに流動パラフィンに溶解したエステルガムを添
加、撹拌機にて全質均等となるまで撹拌して得た組成物
を厚さ500μmとなるようにポリエチレンテレフタレ
ート製の剥離ライナーフィルム上に展延塗布し、ポリエ
ステル製の伸縮性織布で被覆して本発明の皮膚外用貼付
剤を得る。
In the composition shown in Table 1, sodium polyacrylate, dried aluminum hydroxide gel, lactic acid, concentrated glycerin, D-sorbitol solution , sodium carboxymethyl cellulose, kaolin, purified gelatin and purified water were mixed, and liquid paraffin was added to the mixture. The ester gum dissolved in the above was added, and the composition obtained by stirring with a stirrer until the quality became uniform was spread-coated on a release liner film made of polyethylene terephthalate to a thickness of 500 μm. The skin external patch of the present invention is obtained by coating with a stretchable woven fabric.

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0032[Name of item to be corrected] 0032

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0032】実施例17ポリアクリル酸ナトリウム5
g、酸化亜鉛1g、リン酸1g、濃グリセリン30g、
D−ソルビトール液15g、カルボキシメチルセルロー
スナトリウム3g、カオリン5g、精製ゼラチン2g、
精製水29gを混和し、これに流動パラフィン1.5g
に溶解したエステルガム(KE−311:荒川化学工業
(株)製)7.5gを添加、撹拌機にて全質均等となる
まで撹拌して得た組成物を以下実施例1〜8と同様に製
した。
Example 17 Sodium polyacrylate 5
g, zinc oxide 1 g, phosphoric acid 1 g, concentrated glycerin 30 g,
D-sorbitol solution 15 g, sodium carboxymethyl cellulose 3 g, kaolin 5 g, purified gelatin 2 g,
29 g of purified water is mixed, and 1.5 g of liquid paraffin is added to this.
Ester gum dissolved in KE (KE-311: Arakawa Chemical Industry
The composition obtained by adding 7.5 g (manufactured by Co., Ltd.) and stirring with a stirrer until the quality became uniform was produced in the same manner as in Examples 1 to 8 below.

【手続補正5】[Procedure Amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0033[Correction target item name] 0033

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0033】実施例18 ポリアクリル酸ナトリウム5g、合成ケイ酸アルミニウ
ム2g、メタリン酸ナトリウム0.3g、濃グリセリン
30g、D−ソルビトール液15g、カオリン7g、精
製ゼラチン2g、精製水29.7gを混和し、これに流
動パラフィン1.5gに溶解したエステルガム(KE−
311:荒川化学工業(株)製)7.5gを添加、撹拌
機にて全質均等となるまで撹拌して得た組成物を以下実
施例1〜8と同様に製した。
Example 18 5 g of sodium polyacrylate, 2 g of synthetic aluminum silicate, 0.3 g of sodium metaphosphate, 30 g of concentrated glycerin, 15 g of D-sorbitol solution, 7 g of kaolin, 2 g of purified gelatin, and 29.7 g of purified water were mixed. , An ester gum dissolved in 1.5 g of liquid paraffin (KE-
311: Arakawa Chemical Industry Co., Ltd. ( 7.5 g) was added, and a composition obtained by stirring with a stirrer until the quality became uniform was produced in the same manner as in Examples 1 to 8 below.

【手続補正6】[Procedure correction 6]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0047[Correction target item name] 0047

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0047】[0047]

【表6】 [Table 6]

【手続補正7】[Procedure Amendment 7]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0057[Name of item to be corrected] 0057

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0057】 製剤例5 リドカイン含有貼付剤 リドカイン 2.5g エステルガム 7.5g 流動パラフィン 1.5g ポリアクリル酸ナトリウム 5.0g 乾燥水酸化アルミニウムゲル 0.3g 酒石酸 0.5g 濃グリセリン 30 g D−ソルビトール液 15 g 精製水 32.7g カルボキシメチルセルロースナトリウム 3.0g 精製ゼラチン 2.0g 全 量 100 gFormulation Example 5 Lidocaine-containing patch Lidocaine 2.5 g Ester gum 7.5 g Liquid paraffin 1.5 g Sodium polyacrylate 5.0 g Dry aluminum hydroxide gel 0.3 g Tartaric acid 0.5 g Concentrated glycerin 30 g D-sorbitol Liquid 15 g Purified water 32.7 g Sodium carboxymethyl cellulose 3.0 g Purified gelatin 2.0 g Total amount 100 g

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 担持体上に常温で粘着性を有する粘着剤
層を設けて成る皮膚外用貼付剤に於いて、該粘着剤層が
水、粘着付与性樹脂及びその溶解剤、吸油性無機性粉末
を必須の構成成分として成り、その厚さが100〜10
00μmである含水性皮膚外用貼付剤。
1. A skin external patch comprising a carrier and a pressure-sensitive adhesive layer having a pressure-sensitive adhesive property at room temperature, wherein the pressure-sensitive adhesive layer comprises water, a tackifying resin and a dissolving agent thereof, and an oil-absorbing inorganic substance. It consists of powder as an essential constituent and its thickness is 100 to 10
A hydrous external skin patch having a size of 00 μm.
【請求項2】 粘着剤層中に、水15〜60重量%、粘
着付与性樹脂2〜20重量%、粘着付与性樹脂の溶解剤
0.4〜10重量%、吸油性無機性粉末0.1〜30重
量%を必須の構成成分として含有する請求項1に記載の
含水性皮膚外用貼付剤。
2. The pressure-sensitive adhesive layer contains 15 to 60% by weight of water, 2 to 20% by weight of a tackifying resin, 0.4 to 10% by weight of a solubilizer of the tackifying resin, and 0.1. The hydrous external skin patch according to claim 1, which contains 1 to 30% by weight as an essential component.
【請求項3】 粘着付与性樹脂がエステルガムである請
求項1に記載の含水性皮膚外用貼付剤。
3. The hydrous external skin patch according to claim 1, wherein the tackifying resin is an ester gum.
【請求項4】 吸油性無機性粉末がカオリンである請求
項1に記載の含水性皮膚外用貼付剤。
4. The hydrous external skin patch according to claim 1, wherein the oil-absorbing inorganic powder is kaolin.
JP4322428A 1992-11-06 1992-11-06 Hydrous skin external patch with improved usability Expired - Lifetime JP2887548B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4322428A JP2887548B2 (en) 1992-11-06 1992-11-06 Hydrous skin external patch with improved usability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4322428A JP2887548B2 (en) 1992-11-06 1992-11-06 Hydrous skin external patch with improved usability

Publications (2)

Publication Number Publication Date
JPH06145047A true JPH06145047A (en) 1994-05-24
JP2887548B2 JP2887548B2 (en) 1999-04-26

Family

ID=18143562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4322428A Expired - Lifetime JP2887548B2 (en) 1992-11-06 1992-11-06 Hydrous skin external patch with improved usability

Country Status (1)

Country Link
JP (1) JP2887548B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001213768A (en) * 2000-02-01 2001-08-07 Okayama Taiho Pharmaceutical Co Ltd Poultice
JP2003522595A (en) * 2000-02-18 2003-07-29 ドッタ,アンジェロ Patch with fast opening package and device for manufacturing the package
JP2010195763A (en) * 2008-04-23 2010-09-09 Kowa Co External skin patch
JP2013231021A (en) * 2012-05-01 2013-11-14 Jem International Inc Plaster

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001213768A (en) * 2000-02-01 2001-08-07 Okayama Taiho Pharmaceutical Co Ltd Poultice
JP2003522595A (en) * 2000-02-18 2003-07-29 ドッタ,アンジェロ Patch with fast opening package and device for manufacturing the package
JP2010195763A (en) * 2008-04-23 2010-09-09 Kowa Co External skin patch
US8097275B2 (en) 2008-04-23 2012-01-17 Kowa Company, Ltd. External skin patch
JP2013231021A (en) * 2012-05-01 2013-11-14 Jem International Inc Plaster

Also Published As

Publication number Publication date
JP2887548B2 (en) 1999-04-26

Similar Documents

Publication Publication Date Title
AU784779B2 (en) Ultraviolet-shielding adhesive preparation
WO2002043729A1 (en) Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
GB2273044A (en) Medicinal patches for percutaneous administration
JP4422430B2 (en) External patch containing estrogen and / or progestogen
WO2002032431A1 (en) Compositions for external preparations
JP2006206471A (en) Tape preparation
JP3466305B2 (en) Dissolving agent and external preparation containing the dissolving agent
JP4625157B2 (en) Indomethacin patch
WO2000019986A1 (en) Tape material for transcutaneous absorption
JP2008179564A (en) Anti-inflammatory and analgesic plaster
JP2003093434A (en) Elastic poultice for external application
JPH10109945A (en) Plasticizing agent and cataplasm containing the same
JP3276188B2 (en) Patch and method for producing the same
JP4468669B2 (en) Hypoallergenic patch
JP2887548B2 (en) Hydrous skin external patch with improved usability
JP2887549B2 (en) Anti-inflammatory and analgesic skin patch with improved usability
JP5192722B2 (en) External patch
AU2004315561B2 (en) External preparation for treating painful skin wound
JPH06135828A (en) Percutaneous absorption preparation
JPS59181211A (en) Rubber based plaster composition
JPH10316560A (en) Plaster
JP2000256214A (en) Antiphlogistic-sedative plaster
JPH01297069A (en) Tacky adhesive agent composition
JP2001039873A (en) Percutaneous absorption type therapeutic agent for dysuria
JP3612731B2 (en) Anti-inflammatory analgesic topical

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090219

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100219

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110219

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130219

Year of fee payment: 14

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130219

Year of fee payment: 14